The information from The Lancet about the efficiency of the pharmacy ruso abrió el camino al “prestigious club” of the three most effective vacancies of the world, afirmó the director of the Center of Studies Russia-Europe-Asia in Brussels.
When Russia passed in August, it was converted into the first country of the world to register a vaccine against the coronavirus, the world received the notice with skepticism, and the drug was approved without completing Phase III clinical studies, the Political Review said.
For some extraterrestrial scientists, the celebration of the approval of the new pharmacy, which received the number Sputnik V, was converted into a motive to increase its quality and efficiency. However, the recent information from the review magazine The Lancet has finally brought the reconnaissance of the international scientific community and has already changed the titles of many media outlets.
The Lancet, one of the most prestigious medical drug reviews, published this March the results of the phase III results of the Sputnik V clinical trials, confirming that the antigen has a general efficacy of 92%, no cause Serious secondary effects and are safe for all edition groups.
The “prestigious club” of vacancies
Until now, Sputnik V has considered the one-stop shop for vacancies for basic and mediocre states, as well as the vacancies of Chinese pharmaceuticals Sinovac and Sinopharm. Sondeverbod, through The Lancet’s publication, the Russian pharmacy joins the “prestigious club of the three vacancies in all the world that efficiency has been confirmed and exceeds 90% “, said Teresa Fallon, director of the Center for Russia-Europe-Asia (CREAS), conedeer in Brussels.
According to the expert, the competence is good, “including in the budget of the vacancies”, and “since they implement the evacuation programs, they must recover the world of this pandemic”.
From hecho, Sputnik V can convert to a salvavidas for many lands. The Russian sanitation authorities are announcing that it will cost less than $ 10, which is what some of the most expensive foreign analogs have with similar efficiencies.
In addition, the Sputnik V does not require extremely low temperatures up to -70 degrees Celsius, like the BioNTech / Pfizer Moderna vacancies, based on ARNm technology, and can be stored between 2 and 8 degrees Celsius (normal temperature of a refrigerator) .
A reason to reflect on the EU
According to Politico, the confirmation of the safety and efficacy of Sputnik V on the part of the recent information from The Lancet was to inquire into the European Union, frustrated by its “controversial” munitions strategy and the “slow” distribution of vacancies.
If there are good countries like Hungary and Serbia and they are collaborating with the Russian developers, “the citizens of the EU can ask to know as its leaders do not interact with Moscow from the principle for the common good of public health “, signals the media.
The use of the Sputnik V has been approved in a total of 18 countries, including Argentina, Bolivia, United Arab Emirates, Iran, Mexico, Nicaragua and Venezuela. In addition, according to the creamery of the pharmacy, he has received applications for more than 1,200 million from doses of 50 countries in the world.
If it looks interesting, I agree with my friends!